Regenerative medicine company Carmell Therapeutics goes public after SPAC merger
Alpha Healthcare Acquisition Corp. III, a special purpose acquisition company (SPAC) headed by Rajiv Shukla, announced the completion of its $328 million merger with Carmell ... Read More
Carmell Therapeutics to go public via $328m SPAC deal with Alpha Healthcare
Carmell Therapeutics, a phase 2-stage biotechnology platform company, is set to go public through a merger deal with Alpha Healthcare Acquisition Corp. III, a special ... Read More
Humacyte to merge with Alpha Healthcare Acquisition Corp in $1.1bn deal to advance regenerative medicine
Humacyte, Inc., a clinical-stage biotech company based in Durham, North Carolina, has announced a merger with Alpha Healthcare Acquisition Corp. (AHAC), a blank check company. ... Read More